Retinal Vein Occlusion Unknown Status Phase 2 Trials for Ranibizumab (DB01270)

Also known as: Occlusion Retinal Vein / Retinal-vein occlusion / Retinal Vein Occlusions(RVO) / Retinal Vein Occlusion (RVO) / Retinal Vein Occlusions

IndicationStatusPhase
DBCOND0000674 (Retinal Vein Occlusion)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01123564Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein OcclusionTreatment